ArticleFrontiers in pharmacology2022

Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders.

M Dooms et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.